The Role of Cyclic Nucleotides in Atrial Natriuretic Peptide-Mediated Inhibition of Aldosterone Secretion*
- 1 March 1988
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 122 (3) , 799-808
- https://doi.org/10.1210/endo-122-3-799
Abstract
Using freshly isolated bovine adrenal glomerulosa cells we examined the inhibitory effect of atrial natriuretic peptide (ANP) on aldosterone secretion stimulated by agonists that use either the Ca2+-phosphoinositide or cAMP messenger system. In a continuous perifusion system, angiotensin II (AII) induces a prompt initial rise in aldosterone secretion, followed by a sustained secretory response. Both phases of secretion are rapidly and idependently inhibited by ANP. The role of two cyclic nucleotides, cGMP and cAMP, as mediators of this ANP-induced inhibition was examined. The effect of 8-bromo-cGMP (1-100 .mu.M) or (Bu)2cGMP (1-50 .mu.M) on the AII-stimulated rate of secretion was studied in a perifusion system. Either analog, whether added early or late, maximally inhibited by 20-30% only the late or sustained phase of aldosterone secretion. The effect of ANP on cellular cAMP content was examined in a static incubation system. Although ANP caused a reduction in the cAMP content of cells stimulated with either AII or ACTH, it had little or no effect on the cAMP levels in cells stimulated with carbachol. In AII- and ACTH-stimulated cells, the relationship between reduced cAMP content and reduced secretion was explored. In the AII-stimulated cell inhibited by ANP, simple restoration of cAMP content with forskolin did not restore the secretory rate. Pertussis toxin treatment blocked the inhibitory effect of ANP on cAMP content, but did not block its inhibition of secretion. In the ACTH-stimulated cell, reversal of the ANP-induced reduction of cAMP with forskolin, partially restored the stimulated rate of secretion, although restoration of cAMP with a 10-fold higher dose of ACTH did not restore the stimulated rate of secretion in the presence of ANP. These results imply that both the ANP-induced rise in cGMP and the ANP-induced decrease in cellular cAMP content may contribute to the inhibition of steroidogenesis. However, these inhibitory messages do not induce either the magnitude or the temporal pattern of inhibition induced by ANP. Thus, in the adrenal multiple messenger systems may underlie the action of ANP.This publication has 16 references indexed in Scilit:
- Inhibition of aldosterone production by α-human atrial natriuretic polypeptide is associated with an increase in cGMP productionBiochemical and Biophysical Research Communications, 1985
- The temporal integration of the aldosterone secretory response to angiotensin occurs via two intracellular pathways.Journal of Biological Chemistry, 1984
- Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.Proceedings of the National Academy of Sciences, 1984
- Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosaLife Sciences, 1984
- Inhibition of Aldosterone Production by an Atrial ExtractScience, 1984
- Atrial natriuretic factor inhibits adenylate cyclase activityBiochemical and Biophysical Research Communications, 1984
- Calcium: Its Role in the Mechanism of Action of Angiotensin II and Potassium in Aldosterone Production*Endocrinology, 1981
- The role of cyclic AMP in aldosterone production by isolated zona glomerulosa cells.Journal of Biological Chemistry, 1979
- Regulation of steroidogenesis by adrenocorticotropic hormone in isolated adrenal cells. The intermediate role of cyclic nucleotides.Journal of Biological Chemistry, 1979
- Mechanism of β- adrenergic relaxation of smooth muscleNature, 1979